Penny Stock Play

Pennexx Announces its Smartphone, Tablet and Laptop App Development Project and Discusses the Associated Benefits of These Applications Philadelphia, PA, Dec. 21, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pennexx (PNNX) has announced its initiative to creating applications to enhance its current https://yoursocialoffers.com Your Social Offers (YSO) platform. Pennexx has been developing this application in conjunction with OEM manufacturers to be compatible with Android and...Continue reading

Pennexx Reports That It Has Doubled Its Revenue for the Fourth Quarter 2020 and Has Commitments for Revenue for 2021 and 2022 Philadelphia, PA, Dec. 17, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire Pennexx (PNNX) reports it has increased its revenue for the fourth quarter of this year and has a commitment for additional revenue avenues going into 2022. This news represents a significant milestone for the company regarding its continuous commitment to increasing shareholder val...Continue reading

YourSocialOffers (YSO) has Signed Its First National Marketing Agreement Philadelphia, PA, Dec. 14, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pennexx Foods (PNNX): Your Social Marketing Inc. is owned and operated by Mark LePera of Nashville, TN, a business network group. Mr. LePera stated, "Our affiliate network consists of over a million business connections. While utilizing YSO, I can quickly and inexpensively generate new sets of merchants and businesses and expand my ...Continue reading

COVID-19 Vaccine Capable Air Transportation System Patent Awarded to Reflect Scientific for its Liquid Nitrogen Temperature-controlled Cooling and Freezing Systems OREM, Utah, Dec. 02, 2020 (GLOBE NEWSWIRE) Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, announced a patent has been granted by the United States Patent Office for an ultracold shipping and storage contain...er for transportation by air that uses liquid nitrogen technology for cooling. The large state-of-the-art shipping system could carry many thousands of doses of vaccines and utilizes the commercially proven Cryometrix patented cooling and freezing technology that has the flexibility to provide precise temperature control across a wide range of temperatures. The system accommodates payloads ranging from those requiring conventional refrigeration to specialty products such as #COVID-19 and related vaccines that may require temperatures as low as -80 centigrade (-112 Fahrenheit). Systems can be configured to provide for short or long duration shipping cycles, making it an ideal choice for cold chain management. Read more and disclaimer: https://pennystockplay.com/covid-19-vaccine-capable-air-tr/

Generex Inks $50 Million Licensing Deal with China Partners on the Cooperative Development of the Ii-Key Vaccine Platform NOV 18, 2020Generex Inks $50 Million Licensing Deal Generex Inks $50 Million Licensing Deal...Continue reading

Generex Biotechnology Announces Interview with Richard Purcell EVP of R&D on the Yo! Dr.Yo Show with an Update on the Ii-Key COVID Vaccine Program NOV 12, 2020Generex Biotechnology Interview with Richard Purcell Livestream Interview on Friday November 13 at 2 PM EST... MIRAMAR, Fla., Nov. 12, 2020 (GLOBE NEWSWIRE) Generex Biotechnology Corporation (OTCQB:GNBT) today announced that Richard Purcell, Executive Vice President of Research & Development at Generex and NuGenerex Immuno-Oncology will be featured on the Yo! Dr. Yo Show to provide an update on the company’s COVID-19 vaccine development program. The interview will be live streamed at 2:00 PM on Friday, November 13, 2020 at can be heard at the following link: https://streamyard.com/6pykxvt9m4 The Yo! Dr. Yo show is hosted by Dr. Ram Yogendra, MD, PhD, a board-certified anesthesiologist specializing in physiology and #biometrics. He founded #ECAWellness to apply modern science and technology in order to offer a science-based approach to exercise, diet, and health through on-line collaboration with patients. Dr. Yogendra has built a loyal following for his on-line program Yo! Dr. Yo as he engages the audience with live discussions on popular health and wellness topics. On the show, Mr. Purcell will discuss Generex’ progress with developing the Ii-Key-SARS-CoV-2 II-Key COVID-19 vaccine and the power of the Ii-Key platform for vaccine development. He will also discuss the signed agreements with international partners to finalize development and commercialize the Ii-Key vaccine for global markets. Read more and disclaimer: https://pennystockplay.com/generex-biotechnology-interview/